Insulin resistance promotes Lysyl Oxidase Like 2 induction and fibrosis accumulation in non-alcoholic fatty liver disease

Author:

Dongiovanni Paola1,Meroni Marica2,Baselli Guido Alessandro1,Bassani Giulia Alessandra3,Rametta Raffaela1,Pietrelli Alessandro14,Maggioni Marco5,Facciotti Federica6,Trunzo Valentina7,Badiali Sara8,Fargion Silvia12,Gatti Stefano3,Valenti Luca12

Affiliation:

1. Internal Medicine, Fondazione IRCCS Ca’ Granda Ospedale Policlinico Milano, Milan, Italy

2. Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy

3. Department of Surgery, Center for Surgical Research, Fondazione IRCCS Ca’ Granda Ospedale Policlinico Milano, Milan, Italy

4. Bioinformatic Group, Istituto Nazionale Genetica Molecolare (INGM), “Romeo ed Enrica Invernizzi”, Bioinformatic Group, Milan, Italy

5. Pathology, Fondazione IRCCS Ca’ Granda Ospedale Policlinico Milano, Milan, Italy

6. Department of Experimental Oncology, European Institute of Oncology, Milan, Italy

7. Flow Cytometry Service, Fondazione IRCCS Ca’ Granda Ospedale Policlinico Milan, Milan, Italy

8. Surgery, Fondazione IRCCS Ca’ Granda Ospedale Policlinico Milano, Milan, Italy

Abstract

In patients with non-alcoholic fatty liver disease (NAFLD), insulin resistance (IR) associates with fibrosis progression independently of the hepatic inflammation, but the mechanisms are still unclear. We modeled the independent contribution of inflammation (non-alcoholic steatohepatitis: NASH) by exploiting the methionine-choline deficient (MCD) diet, and that of IR by insulin receptor (InsR) haploinsufficieny (InsR+/–) in the pathogenesis of liver fibrosis in C57BL/6 mice. We confirmed the study findings in 96 patients with NAFLD. InsR+/– enhanced hepatic fat content and impaired hepatic insulin signaling leading to Forkhead box protein O1 (FoxO1) accumulation in MCD-fed mice. Remarkably, despite reduced inflammation and hampered transdifferentiation of hepatic stellate cells (HSCs), InsR+/– promoted hepatic fibrosis accumulation, which correlated with the induction of the Lysyl Oxidase Like 2 (Loxl2), involved in matrix stabilization. Loxl2 up-regulation was not a cell autonomous property of insulin resistant HSCs, but was dependent on microparticles (MPs) released specifically by insulin resistant hepatocytes (HEPs) exposed to fatty acids. The mechanism entailed FoxO1 up-regulation, as FoxO1 silencing normalized Loxl2 expression reversing fibrosis in InsR+/– MCD-fed mice. Loxl2 up-regulation was similarly detected during IR induced by obesity, but not by lipogenic stimuli (fructose feeding). Most importantly, LOXL2 up-regulation was observed in NAFLD patients with type 2 diabetes (T2D) and LOXL2 hepatic and circulating levels correlated with histological fibrosis progression. IR favors fibrosis deposition independently of the classic ‘inflammation – HSC transdifferentiation’ pathway. The mechanism entails a cross-talk between enhanced lipotoxicity in insulin resistant HEPs and Loxl2 production by HSCs, which was confirmed in patients with diabetes, thereby facilitating extracellular matrix (ECM) stabilization.

Publisher

Portland Press Ltd.

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3